A reevaluation of integrins as regulators of angiogenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12205444.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pharmacological agents directed against the integrins alpha(v)beta(3) and alpha(v)beta(5) have been reported to inhibit angiogenesis. However, genetic ablations of the genes encoding these integrins fail to block angiogenesis and in some cases even enhance it. This apparent paradox suggests the hypotheses that these integrins are negative regulators of angiogenesis and that the drugs targeting them may be acting as agonists rather than antagonists.
Medical subject headings
- Integrins
- Neovascularization, Pathologic
- Neovascularization, Physiologic